Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q3 2019 · 10-Q
Revenue$452.00M$452.00M+4.5% vs Q3 2018 Net Income-$15.70M-$15.70MN/M vs Q3 2018 EPS Diluted-$0.51-$0.51N/M vs Q3 2018 Operating Income$59,000,000+31.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$38,500,000+104.8% Margins · derivedOperating margin13.1%+2.6 pt vs Q3 2018
Net margin-3.5%+1.4 pt vs Q3 2018
ended Sep 30, 2019 · filed Nov 6, 2019 · 37 d after period end